ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Lexaria Bioscience Corporation

Lexaria Bioscience Corporation (LEXX)

3.63
-0.08
(-2.16%)
Closed March 28 04:00PM
3.64
0.01
(0.28%)
After Hours: 07:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.63
Bid
3.63
Ask
3.82
Volume
168,460
3.59 Day's Range 3.92
0.6488 52 Week Range 6.85
Market Cap
Previous Close
3.71
Open
3.70
Last Trade
50
@
3.63
Last Trade Time
Financial Volume
$ 635,296
VWAP
3.7712
Average Volume (3m)
499,457
Shares Outstanding
10,276,641
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Lexaria Bioscience Corporation

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some ins... Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. Show more

Sector
Pharmaceutical Preparations
Industry
Crude Petroleum & Natural Gs
Headquarters
Kelowna, British Columbia, Can
Founded
2014
Lexaria Bioscience Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LEXX. The last closing price for Lexaria Bioscience was $3.71. Over the last year, Lexaria Bioscience shares have traded in a share price range of $ 0.6488 to $ 6.85.

Lexaria Bioscience currently has 10,276,641 shares outstanding.

LEXX Latest News

Form 8-K - Current report

0001348362false00013483622024-02-292024-02-290001348362lxrp:CommonStocksMember2024-02-292024-02-290001348362lxrp:WarrantsMember2024-02-292024-02-290001348362dei:BusinessContactMember2024-02-292024...

Form 8-K - Current report

0001348362false00013483622024-02-142024-02-14iso4217:USDxbrli:sharesiso4217:USDxbrli:shares  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 2 )*  ...

Form 8-K - Current report

0001348362false00013483622024-01-292024-01-29iso4217:USDxbrli:sharesiso4217:USDxbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.26-6.683804627253.8943.34213133.65788932CS
40.8530.57553956832.786.852.319923614.16299846CS
122.35183.593751.286.851.24994573.49414144CS
262.6499270.370370370.98016.850.852961203.02805879CS
521.1244.62151394422.516.850.64882095312.40769375CS
156-1.67-31.50943396235.312.50.64883603945.27433927CS
260-0.42-10.37037037044.0512.50.64883551755.32814874CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

LEXX Discussion

View Posts
lanny9 lanny9 3 days ago
https://www.biospace.com/article/wegovy-cardiovascular-approval-furthers-march-into-new-indications/
👍️ 1
lanny9 lanny9 7 days ago
Huge for the sector and for a potential pill or sublingual version with few, if any, side effects.

https://www.nbcnews.com/health/health-news/medicare-will-cover-wegovy-reduce-heart-disease-risk-rcna143479
👍️ 1
mazzjazz mazzjazz 1 week ago
Yes and bought by people who see an this as a value entry point. What's that saying :), Be greedy when others are fearful and be fearful when others are greedy.
๐Ÿ‘๏ธ0
all4weed all4weed 1 week ago
The next leg up will be 5-8 million daily volume and price, which is going 300-400%from these levels.

I am waiting on some big pharma or bug tobacco partnership that will take to 20 to 30x

That can happen anytime between now and year end

👍️ 1
Abundance88 Abundance88 1 week ago
and it's still being bought as it does!
👍️ 1
benchman benchman 1 week ago
It may be much ado about nothing, but it's still selling off
๐Ÿ‘๏ธ0
Shawking Shawking 1 week ago
Lexariaโ€™s Shakespearian Correction โ€“ Much Ado About Nothing
https://www.letstoke.biz/_files/ugd/449582_f3c7ffb8161b40a1a2cd3dc4651cd1df.pdf
๐Ÿ‘๏ธ0
lanny9 lanny9 2 weeks ago
👍️ 1
lanny9 lanny9 2 weeks ago
👍️ 1
lanny9 lanny9 2 weeks ago
👍️ 1
lanny9 lanny9 2 weeks ago
👍️ 3
Shawking Shawking 2 weeks ago
Needs a delivery system. DehydraTECH?
https://www.msn.com/en-ca/health/other/revealed-cannabis-deadly-effect-on-melanoma-skin-cancer-cells-new-study-finds/ar-BB1jnVEa?ocid=msedgntp&pc=DCTS&cvid=75143799a3684685955138ffe187c061&ei=24
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
https://ir.lexariabioscience.com/news-events/press-releases/detail/244/lexaria-appoints-nelson-cabatuan-as-chief-financial-officer
๐Ÿ‘๏ธ0
MasterBidder MasterBidder 2 weeks ago
Iโ€™d do dirty, dirty things for that salaryโ€ฆ just saying
๐Ÿ‘๏ธ0
harlem111 harlem111 2 weeks ago
BUMKA GETS A $1000 A DAY (including weekends) FOR DOING soft piece on access wire or BS lunch with ted O --I ' LL TAKE THE JOB FOR HALF THAT AND SO WILL MANY OTHERS
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
Executive compensation is obviously on our backs as well as studies and patents etc. but IMO the pros outdo the cons and that's why I'm still here. It's easy to imagine we're not getting enough bang for our bucks until we get proven otherwise. I like to think: Would I like to do Bunka's job for the amount he gets paid and the answer is a huge "No"! You couldn't pay me enough because I'm sure he has sacrificed a lot in his personal life. I'm okay with the amount our leaders are taking as I can see progress. I wish it was faster but gotta stay patient if I want to land some Big Pharma bucks!
๐Ÿ‘๏ธ0
abrooklyn abrooklyn 2 weeks ago
46.25%
๐Ÿ‘๏ธ0
MasterBidder MasterBidder 2 weeks ago
Any idea what executive compensation is tied to? Seems thatโ€™s more what the investors are supporting by helping to absorb the warrants etc?
๐Ÿ‘๏ธ0
harlem111 harlem111 2 weeks ago
its a green day -- i am happy for that glta
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
This is typical for an R&D company that doesn't have much revenue. Hopefully everyone's averaged down enough they can absorb supporting the company as you mentioned.
๐Ÿ‘๏ธ0
SageVoyager42 SageVoyager42 2 weeks ago
It's also pretty clear that LEXX is funding its research off the backs of investors. They make money every single time these large warrants are sold and they use it for funding.

This is not fraud, but it's also doesn't give stock holders a good feeling. Some have waited for years for this stock to go up.
๐Ÿ‘๏ธ0
SageVoyager42 SageVoyager42 2 weeks ago
I have done my due diligence and then I came across this board. I am just trying to get an idea of what everyone is going through.
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
LEXX does not commit fraud or they would be quickly out of business. You can't trust posters on these online bull boards to tell the truth. Everyone has their own agenda. Think about how the individual posts might benefit the individual if taken as verbatim! Read between the lines and Do Your own Due Diligence through other sources besides the bull boards. Good Luck.
๐Ÿ‘๏ธ0
SageVoyager42 SageVoyager42 2 weeks ago
What are you going to do? Did you sell? Sorry to hear about that loss man...

This stock seems to be fraught with fraud.
๐Ÿ‘๏ธ0
SageVoyager42 SageVoyager42 2 weeks ago
How can you say it's been going up slowly?? It literally sky rocketed the past few weeks.

Can you catch me up to pace... I've been just checking out LEXX and there is years of comments talking about fraud and that type of stuff...
๐Ÿ‘๏ธ0
SageVoyager42 SageVoyager42 2 weeks ago
Can you explain exactly what you mean? I'm new to LEXX and just trying to catch up. Literally years of posts of whats going on. Can you give me a summary? Are you in the stock?
๐Ÿ‘๏ธ0
SageVoyager42 SageVoyager42 2 weeks ago
I'm all new to this LEXX. I've been reading through what you guys have been through in the last few years with LEXX issuing warrants and the pump and dumps.

Many of your posts like a year ago, were talking about how LEXX was stealing from shareholders through these warrants

Can anyone give more information? Should we stay in this stock or not? Seems like a lot of fraud and mismangment going on but we can all see the patents and future prospects of LEXX

Can anyone provide me some insight?
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
I just read through the S-1 just issued and I don't see where it says the warrants have been exercised. Not that they haven't been. I'm not sure how you know this. Could you provide a link of some sort? Also, where is it written in the offering or elsewhere that exercised warrants have a 6 month holding period. Not trying to argue...just want to understand this. Thanks.
๐Ÿ‘๏ธ0
all4weed all4weed 2 weeks ago
Warrants exercised have a holding period of 6 months
1.6 mil warrants have been exercised
๐Ÿ‘๏ธ0
Shawking Shawking 2 weeks ago
I call it an amazing gift from the short sellers to anyone wishing to get in for the first time or add to their positions!
👍️ 1
mazzjazz mazzjazz 2 weeks ago
Yep. The hawks have all been waiting for a chance to pump comments. Rest and we'll see about resume.
๐Ÿ‘๏ธ0
harlem111 harlem111 2 weeks ago
just look. at the numbers not my post-- but something is wrong here
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
Real classy there Harlem! Blocking now!
👍️ 2
harlem111 harlem111 2 weeks ago
BUNKA AND TED O RIP OFF AND MAYBE YOU TOO == POS
๐Ÿ‘๏ธ0
abrooklyn abrooklyn 2 weeks ago
now 38.375%
๐Ÿ‘๏ธ0
Abundance88 Abundance88 2 weeks ago
AKA right after an offering where warrants are immediately exercisable and there's an obvious spike caused by pump and dump info flooding the media...be more careful , lol.
๐Ÿ‘๏ธ0
all4weed all4weed 2 weeks ago
Nothing goes straight up. It was profit taking on technicals.as.RSI was.oversold.
It will consolidate and move much higher , still expecting it to close 5-10% pull back today's close.

I think it will hit $20 in next 2 months and it's good it is going up slowly building new supports along the way
👍️ 2
MasterBidder MasterBidder 2 weeks ago
Thereโ€™s the LEXXY weโ€™re familiar with
๐Ÿ‘๏ธ0
jb128 jb128 2 weeks ago
Itโ€™s called a pump and dump. Look it up
👍️ 1
harlem111 harlem111 2 weeks ago
WTF ????
๐Ÿ‘๏ธ0
Shawking Shawking 2 weeks ago
👍️ 1
Monksdream Monksdream 2 weeks ago
LEXX new 52 week high
๐Ÿ‘๏ธ0
Shawking Shawking 3 weeks ago
Special Report: Lexaria has a week for the record books
https://www.letstoke.biz/_files/ugd/449582_b11b869ac5744f18a682429ffbf12660.pdf
😂 1
Abundance88 Abundance88 3 weeks ago
The beauty of DehydraTECH is that LEXX can almost always improve any lipophillic drug. A large pharma company could be using DehydraTECH with a great many of their products and keep using it for new ones as they are approved!
๐Ÿ‘๏ธ0
Miladad Miladad 3 weeks ago
I liked the dehydratech technology, the market was over bought in my opinion and the chart wasn't that bad at the time. It pretty much tanked from 6.50 to 4 right after I got in. So, yes I stupidly put over $600,000 in a stock that wasn't liquid and had very little revenue. I thought the FDA application or a deal would come much sooner. Thanks for the insult!
👍️ 1
hdhick hdhick 3 weeks ago
From โ€œThe Telegraphโ€


Ozempic maker reveals weight loss pill twice as effective as jab

The maker of weight loss drugs Ozempic and Wegovy has unveiled a new blockbuster obesity pill intended to help patients shed weight dramatically faster than its existing jabs.

Novo Nordisk said early trials for its experimental obesity drug amycretin revealed patients were able to lose more than 13pc of their weight after 12 weeks, compared to weight loss of around 6pc for its Wegovy treatment.

The Danish drugmaker makes both the weight-loss jab Wegovy and Ozempic, a diabetes drug used off-label to treat obesity.

It has been racing to keep up with ballooning demand for the treatments in the past few months, recording a 38pc jump in sales of weight-loss and obesity jabs in 2023 to DKK 215bn (ยฃ24bn).

Novo Nordisk chief executive Lars Fruergaard Jorgensen said on Thursday that the obesity market was โ€œa tremendous runwayโ€. Analysts forecast that it could be worth $90bn (ยฃ70bn) in the coming years.
๐Ÿ‘๏ธ0
Shawking Shawking 3 weeks ago
https://www.msn.com/en-ca/health/other/obesity-drug-wegovy-is-approved-to-cut-heart-attack-and-stroke-risk-in-overweight-patients/ar-BB1jzFG3?ocid=msedgntp&pc=DCTS&cvid=2c4aee8abeb143b1929c74cb4214ea55&ei=210
The FDA cautioned that Wegovy carries the risk of serious side effects, including thyroid tumors and certain cancers. Other possible side effects can include low blood sugar; pancreas, gallbladder, kidney or eye problems; and suicidal behavior or thinking.

About a third of the more than 17,600 participants in the clinical trial reported serious side effects. About 17% in the group that took Wegovy and about 8% of those who received placebo left the study because of those effects.
๐Ÿ‘๏ธ0
codfather codfather 3 weeks ago
When did you think LEXX was ever worth $500000 investment?
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 weeks ago
I decided to paste a 4yr
๐Ÿ‘๏ธ0
Abundance88 Abundance88 3 weeks ago
LEXX hasn't been above $6 since Nov. 2021 !
👍️ 1

Your Recent History

Delayed Upgrade Clock